28 results
8-K
EX-10.1
MIRM
Mirum Pharmaceuticals Inc
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
of confidentiality. Rather, you will be expected to use only that information which is generally known and used by persons with training and experience comparable
8-K
EX-2.1
gnlo27b
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
ljihs5qz
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
8-K
EX-10.1
crifprphsyeg5
27 Dec 19
Departure of Directors or Certain Officers
4:15pm
DRS
EX-10.9
n7nyam68p bu
27 Dec 19
Draft registration statement
12:00am
DRS
EX-10.15
sugoq d0h72k
27 Dec 19
Draft registration statement
12:00am
S-1
EX-10.9
zzfhuv7sulhqgivg0d
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.13
yyocr5j
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.14
8o3gsjt7160u7krpoggf
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.12
x1ny7w emxi7kou
21 Jun 19
IPO registration
3:24pm